ArticleComputational and structural biotechnology journal2023
MNNMDA: Predicting human microbe-disease association via a method to minimize matrix nuclear norm.
Article in Computational and structural biotechnology journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- Machine learning-driven data perturbation techniques for privacy-preserving data mining.Scientific reports · 2026Article
- A deep learning approach for solving a fractional order Monkeypox transmission model using a harmonic neural network optimized with SGDM.Scientific reports · 2026Article
- High-fidelity machine learning models for predicting antibacterial effects of cerium oxide nanoparticles across bacterial strains.Discover nano · 2026Article
- Predictive modeling of influenza strain drugs using temperature-based topological indices and regression analysis via multi-criteria decision making techniques.Scientific reports · 2026Article
- Integrative analysis of immune and microbial subtypes predicts immunotherapy response in stomach adenocarcinoma.Microbiology spectrum · 2026Article
- Optimizing feature selection in cancer microarray data using a heap-driven evolutionary framework for high-dimensional spaces.Scientific reports · 2026Article
- Endophyte-mediated biosynthesis of biogenic nanoparticles: mechanisms and biomedical applications.Archives of microbiology · 2026Review
- Microbiome dysbiosis and chemotherapy resistance in acute myeloid leukemia (AML).NPJ biofilms and microbiomes · 2025Review
- Article
- Nitrogen-doped carbon dots in food sensing: a review of detection mechanisms and applications.RSC advances · 2025Review
- Emerging nano sensing technologies for the detection of biological and chemical food toxins.RSC advances · 2025Review
- Serological Evidence of Lassa Virus Exposure in Non-Viruses · 2025Article
- Predicting Potential Microbe-Disease Associations Based on Heterogeneous Graph Random Attention Neural Network and Neural Collaborative Filtering.Interdisciplinary sciences, computational life sciences · 2025Article
- DTI-RME: a robust and multi-kernel ensemble approach for drug-target interaction prediction.BMC biology · 2025Article
- A new approach for microbe-disease association prediction: incorporating representation learning of latent relationships.BMC medical informatics and decision making · 2025Article
- Ensemble learning based on matrix completion improves microbe-disease association prediction.Briefings in bioinformatics · 2025Article
- Harnessing dual variational autoencoders to decode microbe roles in diseases for traditional medicine discovery.Frontiers in pharmacology · 2025Article
- Predicting human miRNA disease association with minimize matrix nuclear norm.Scientific reports · 2024Article
- Predicting disease-associated microbes based on similarity fusion and deep learning.Briefings in bioinformatics · 2024Article
- ANS-SCMC: A matrix completion method based on adaptive neighbourhood similarity and sparse constraints for predicting microbe-disease associations.Journal of cellular and molecular medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Identifying the potential associations between microbes and diseases is the first step for revealing the pathological mechanisms of microbe-associated diseases. However, traditional culture-based microbial experiments are expensive and time-consuming. Thus, it is critical to prioritize disease-associated microbes by computational methods for further experimental validation. In this study, we proposed a novel method called MNNMDA, to predict microbe-disease associations (MDAs) by applying a Matrix Nuclear Norm method into known microbe and disease data. Specifically, we first calculated Gaussian interaction profile kernel similarity and functional similarity for diseases and microbes. Then we constructed a heterogeneous information network by combining the integrated disease similarity network, the integrated microbe similarity network and the known microbe-disease bipartite network. Finally, we formulated the microbe-disease association prediction problem as a low-rank matrix completion problem, which was solved by minimizing the nuclear norm of a matrix with a few regularization terms. We tested the performances of MNNMDA in three datasets including HMDAD, Disbiome, and Combined Data with small, medium and large sizes respectively. We also compared MNNMDA with 5 state-of-the-art methods including KATZHMDA, LRLSHMDA, NTSHMDA, GATMDA, and KGNMDA, respectively. MNNMDA achieved area under the ROC curves (AUROC) of 0.9536 and 0.9364 respectively on HDMAD and Disbiome, better than the AUCs of compared methods under the 5-fold cross-validation for all microbe-disease associations. It also obtained a relatively good performance with AUROC 0.8858 in the combined data. In addition, MNNMDA was also better than other methods in area under precision and recall curve (AUPR) under the 5-fold cross-validation for all associations, and in both AUROC and AUPR under the 5-fold cross-validation for diseases and the 5-fold cross-validation for microbes. Finally, the case studies on colon cancer and inflammatory bowel disease (IBD) also validated the effectiveness of MNNMDA. In conclusion, MNNMDA is an effective method in predicting microbe-disease associations. Availability: The codes and data for this paper are freely available at Github https://github.com/Haiyan-Liu666/MNNMDA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.